← Back to all trials
Not Yet Recruiting
NCT07825376
Branching Scenario-Based Education in Coronary Artery Disease
Conditions: Coronary Arterial Disease (CAD)
Sex: All
Ages: 18 Years – 65 Years
Healthy volunteers: No
Phase: NA
Enrollment: 54
Sponsor: Abant Izzet Baysal University
Location: Bolu Abant İzzet Baysal University Bolu
Summary
This randomized controlled trial aims to evaluate the effects of nurse-led branching scenario-based education delivered through virtual reality and tablet on cardiovascular disease risk awareness and adherence to antiplatelet medication in patients with coronary artery disease. Participants will be randomly assigned to a virtual reality education group, a tablet-based education group, or a control group receiving routine hospital education. Cardiovascular disease risk awareness and medication adherence will be assessed before and after the educational intervention and during follow-up.
Eligibility Criteria
Inclusion Criteria:
* Aged 18-65 years.
* Diagnosed with coronary artery disease.
* Newly initiated on antiplatelet therapy.
* Conscious and able to communicate.
* Physically and cognitively able to use a virtual reality headset.
* Able to read, write, and understand Turkish.
* Willing to provide written informed consent.
* Willing to participate in the education and follow-up process.
* Has not previously received education about coronary artery disease.
* Able to use a smartphone.
Exclusion Criteria:
* Cognitive impairment or mental illness preventing communication.
* Visual or hearing impairment preventing participation in the virtual reality education.
* Participation in another clinical study at the same time.
* Diagnosis of malignant disease.
* Bleeding disorder or active bleeding risk.
* Hospitalization within the previous 3 months due to acute myocardial infarction, stroke, or another serious cardiovascular event.
* Unable to understand the educational materials.
* Refusal to provide written informed consent.
Source: ClinicalTrials.gov (NCT07825376). StuddyBuddy aggregates publicly available trial information.